ImmunoGenesis

0 followers


ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.

Industries

Headquarters

Stage

Employees

Links

Org chart

Jim Barlow

Collapse
Annemarie Moseley
Acting Chief Medical Officer
Federica Pericle
Chief Scientific Officer
Michael A. Curran
Founder & SAB Head
Federica O’Brien
Strategic Finance Consultant & CFO
Charles Schweizer
SVP, Clinical Development
Matthew Hemberger
Senior Director, CMC & Quality
Matt H.
Executive Director Of CMC And Quality